Tagged: cebiotex

CataloniaBio Member Cebiotex Crowdequity Round Now Live on CapitalCell: Fighting Pediatric Cancer

Cebiotex, a CataloniaBio member, has launched a new crowdequity campaign to raise €650,000 through CapitalCell in order to ensure its first drug, CEB-01 for post-op treatment of soft-tissue sarcomas, reaches pediatric oncology. The campaign is part of a larger €1.6-million round of funding; since launching, the… Read More

Exclusive: Bioprognos CEO Sergio Calleja Discusses Crowdfunding with Spanish Platform Capital Cell

Bioprognos, a Barcelona-based biotech company that seeks to improve both clinical outcomes and quality of life for cancer patients ―as well as other diseases (cardiovascular, neurological or endocrine)― through the development of innovative tools for non-invasive, accurate detection from biomarkers found in a simple blood… Read More

Send this to a friend